Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Splenomegaly 1Primary Myelofibrosis 1Neoplasm Metastasis 1Melanoma 1Leukemia 1Epidermolysis Bullosa Dystrophica 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Anemia 1Adenocarcinoma 1

Interventions

Epoetin Alfa 10Darbepoetin alfa 8ferric carboxymaltose 7fludarabine 4Cyclophosphamide 4Busulfan 4Blood Transfusion 4fludarabine phosphate 3Filgrastim 3Erythrocyte Transfusion 3Cyclosporine 3Biopsy 3Antilymphocyte Serum 3thymoglobulin 2ruxolitinib 2iron isomaltoside 1000 2ferrous sulfate 2ferrous fumarate 2ferric gluconate 2Vitamin B 12 2Thiotepa 2Therapeutics 2Taxes 2Surveys and Questionnaires 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Lenalidomide 2Folic Acid 2Ferric Oxide, Saccharated 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anemia × ON 01910 × Clear all
NCT02730884 2020-08-07

Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 6 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Splenomegaly, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡